Selective 5′ ligation tagging of RNA

• US 9,963,735 B2
• Filed: 10/09/2012
• Issued: 05/08/2018
• Est. Priority Date: 08/17/2007
• Status: Active Grant

• Current Assignee: Illumina Incorporated
• Original Assignee: Epicentre Technologies Corporation (Illumina Incorporated)
• Inventors: Jendrisak, Jerome, Dahl, Gary A., Vaidyanathan, Ramesh
• Primary Examiner(s): Pande, Suchira
• Application Number:
  US13/647,940
• Publication Number:
  US 20130029326A1
• Time in Patent Office: 2,037 Days
• Field of Search: None
• CPC Class Codes: C12N 15/1096 cDNA Synthesis; Subtracted cDNA library construction, e.g. RT, RT-PCR
• CPC Class Codes: C12Q 1/6806 Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay C12Q1/6804 takes precedence
• CPC Class Codes: C12Q 1/6855 Ligating adaptors
• CPC Class Codes: C12Q 2521/525 Phosphatase
• CPC Class Codes: C12Q 2525/125 incorporating agents resulting in resistance to degradation
• CPC Class Codes: C12Q 2525/207 siRNA, miRNA

Abstract

The present invention provides novel compositions, kits and methods employing RNA 5′ polyphosphatases, RNA 5′ monophosphatases, capping enzymes, decapping enzymes, nucleic acid pyrophosphatases and RNA ligases, as well as other enzymes, for selective 5′ ligation tagging of desired classes of RNA molecules that differ with respect to particular chemical moieties on their 5′ ends. The 5′ tagged RNA molecules can be used for synthesis of tagged first-stand cDNA, double-stranded cDNA, and sense or antisense RNA for a variety of uses.

Claims

1. A method for generating 5′

-ligation-tagged RNA from RNA in a sample that is uncapped and has a 5′

polyphosphate group, comprising;

(A) providing;

(i) a sample that contains uncapped RNA that has a 5′

polyphosphate group;

(ii) a RNA 5′

polyphosphatase comprising the sequence of amino acids 35 to 200 of SEQ ID NO;

2, wherein the polyphosphatase does not comprise the sequence of amino acids 1 to 34 of SEQ ID;

2;

(iii) an acceptor oligonucleotide that exhibits a tag; and

(iv) a RNA ligase;

(B) contacting the sample with the RNA 5′

polyphosphatase under conditions and for sufficient time wherein the uncapped RNA that has a 5′

polyphosphate group is converted to RNA that has a 5′

monophosphate group; and

(C) contacting the sample from step (B) with the acceptor oligonucleotide and the RNA ligase under conditions and for sufficient time wherein 5′

-ligation-tagged RNA is generated.

2. The method of claim 1, wherein the method further comprises the steps of:

providing a poly(A) polymerase and ATP; and

contacting the sample with the poly(A) polymerase and ATP under conditions and for sufficient time wherein a poly(A) tail is added to the 3′

-ends of the RNA molecules in the sample and RNA that has a poly(A) tail is generated.

3. The method of claim 1, wherein the sample provided in step (A) contains capped RNA or RNA that has a 5′

monophosphate group, but the 5′

-ligation-tagged RNA is generated only from the RNA in the sample that is uncapped and has a 5′

polyphosphate group, and not from capped RNA or the RNA in the sample that has a 5′

monophosphate group, wherein the method further comprises the substeps of;

providing an RNA 5′

monophosphatase; and

,

prior to step (B), contacting the sample with the RNA 5′

monophosphatase under conditions and for sufficient time wherein RNA in the sample that has a 5′

monophosphate group is converted to RNA that has a 5′

hydroxyl group; and

inactivating or removing the RNA 5′

monophosphatase.

4. The method of claim 1, wherein the sample contains capped RNA and the method additionally comprises generating 5′

-ligation-tagged RNA from the capped RNA, wherein the method further comprises the substeps of;

providing a nucleic acid pyrophosphatase or decapping enzyme; and

,

prior to step (C), contacting the sample with the nucleic acid pyrophosphatase or the decapping enzyme under conditions and for sufficient time wherein the capped RNA in the sample is converted to RNA that has a 5′

monophosphate group.

5. The method of claim 1, wherein the sample comprises a first sample that contains RNA derived from cells of a first type or a first condition or from a first environment, and wherein the method further comprises subtraction from the 5′

-ligation-tagged RNA generated from the first sample those RNA molecules that are also present in a second sample derived from cells of a second type or a second condition or from a second environment, thereby generating a population of 5′

-ligation-tagged RNA molecules derived from RNA that is present only in the first sample but absent in the second sample, the method further comprising the steps of;

(i) providing the 5′

-ligation-tagged RNA generated from the first sample, and a second sample that contains RNA derived from cells of a second type or a second condition or from a second environment;

(ii) preparing first-strand cDNA by reverse transcription of the RNA in the second sample and removing the RNA from said first-strand cDNA;

(iii) annealing to the 5′

-ligation-tagged RNA generated from the first sample the first-strand cDNA prepared from the RNA from the second sample under conditions and for sufficient time wherein a hybridization complex is formed between the 5′

-ligation-tagged RNA generated from the first sample and the first-strand cDNA prepared from RNA from the second sample; and

(iv) treating the hybridization complex with RNase H under conditions and for sufficient time wherein the RNA to which the cDNA is annealed is digested, and subtracted 5′

-ligation-tagged RNA consisting of 5′

-ligation-tagged RNA derived from RNA that is present only in the first sample but absent in the second sample is generated.

6. The method of claim 5, wherein the acceptor oligonucleotide that is provided in step (A) for generating 5′

-ligation-tagged RNA from RNA in the first sample contains an affinity molecule, and the method further comprises the steps of;

providing a solid surface to which an affinity-binding substance that is capable of binding the affinity molecule is attached; and

,

either prior to or after step (iv), contacting the 5′

-ligation-tagged RNA generated from the first sample to the solid surface under conditions and for sufficient time wherein the 5′

-ligation-tagged RNA from the first sample binds to the solid surface to which the affinity-binding substance is attached, and the 5′

-ligation-tagged RNA derived from RNA in the first sample is captured on the solid surface.

7. The method of claim 1, wherein the method further comprises synthesizing first-strand cDNA from the 5′

-ligation-tagged RNA, wherein the method further comprises the steps of;

providing an RNA-dependent DNA polymerase;

providing a first-strand cDNA synthesis primer that is complementary to the 5′

-ligation-tagged RNA; and

contacting the 5′

-ligation-tagged RNA with the first-strand cDNA synthesis primer and the RNA-dependent DNA polymerase under conditions and for sufficient time wherein first-strand cDNA that is complementary to the 5′

-ligation-tagged RNA is synthesized; and

optionally, adding a homopolymeric sequence to the 3′

end of the RNA in the sample or to the 3′

end of the 5′

-ligation-tagged RNA;

wherein the first-strand cDNA synthesis primer comprises a sequence wherein at least its 3′

end exhibits a sequence selected from the group consisting of;

a sequence that is complementary to the homopolymeric sequence at the 3′

end of the RNA in the sample or to the 3′

end of the 5′

-ligation-tagged RNA;

a sequence that is complementary to a known sequence at the 3′

end of one or more RNA molecules;

a sequence that is complementary to one or more internal regions of one or more RNA molecules;

a collection of all possible sequences wherein each sequence is random;

a sequence that is complementary to a poly(A) tail, selected from the group consisting of an oligo(dT)_n sequence, an oligo(dU)_n sequence, an oligo(U)_n sequence, an oligo(dT)_n X anchored sequence, an oligo(dU)_nX anchored sequence, and an oligo(U)_n X anchored sequence; and

a sequence that is complementary to an oligonucleotide tag that is added to the 3′

end of the RNA in the sample or to the 3′

end of the 5′

-ligation-tagged RNA;

wherein the first-strand cDNA synthesis primer optionally exhibits a specific 5′

sequence which is 5′

- of the sequence exhibited at its 3′

end;

wherein said specific 5′

sequence is capable of serving as a template for synthesis of second-strand cDNA that exhibits a specific 3′

sequence that is complementary to the specific 5′

sequence and that provides a site for specific priming of second-strand cDNA.

8. The method of claim 7, wherein the method further comprises the steps of:

providing RNase H and RNase I; and

contacting the sample containing first-strand cDNA with the RNase H and the RNase I under conditions and for sufficient time wherein the RNA is digested.

9. The method of claim 7, wherein the method further comprises the steps of:

providing a DNA-dependent DNA polymerase; and

contacting the first-strand cDNA with the DNA-dependent DNA polymerase under conditions and for sufficient time wherein double-stranded cDNA is synthesized;

wherein the method further comprises the steps of;

providing a second-strand cDNA synthesis primer that is complementary to the portion of the first-strand cDNA that is complementary to the acceptor oligonucleotide provided in step (A), and a DNA-dependent DNA polymerase; and

contacting the second-strand cDNA synthesis primer and the DNA-dependent DNA polymerase with the first-strand cDNA under conditions and for sufficient time wherein double-stranded cDNA is synthesized;

wherein the DNA-dependent DNA polymerase is the same as the RNA-dependent DNA polymerase provided for synthesis of first-strand cDNA;

or

wherein the DNA-dependent DNA polymerase is different from the RNA-dependent DNA polymerase provided for synthesis of first-strand cDNA.

10. The method of claim 9, wherein the 5′

portion of the acceptor oligonucleotide, the 5′

-portion of the first-strand cDNA synthesis primer or the 5′

-portion of the second-strand cDNA synthesis primer exhibits a sequence for one strand of a double-stranded RNA polymerase promoter and the method further comprises;

providing an RNA polymerase that can synthesize RNA using the double-stranded RNA polymerase promoter for which a sequence for one strand is exhibited in the acceptor oligonucleotide, the first-strand cDNA synthesis primer, or the second-strand cDNA synthesis primer; and

contacting the double-stranded cDNA with the RNA polymerase under conditions and for sufficient time wherein RNA is synthesized.

11. The method of claim 9, wherein the acceptor oligonucleotide, the first-strand cDNA primer, or the second-strand cDNA primer contains or is joined to an affinity molecule, and the method further comprises the steps of:

providing a solid surface that is covalently or non-covalently coated with an affinity binding substance that is capable of specifically binding the affinity molecule; and

,

either prior to or following the step in which it is involved, contacting the acceptor oligonucleotide, the first-strand cDNA primer, or the second-strand cDNA primer that is chemically joined to the affinity molecule under conditions and for sufficient time wherein it binds to affinity binding substance that is joined to the solid surface.

12. The method of claim 11, wherein the 5′

ligation-tagged RNA, first-strand cDNA, or second-strand cDNA that is synthesized contains an affinity molecule and said 5′

-ligation-tagged RNA, first-strand cDNA, or second-strand cDNA that contains the affinity molecule is captured, isolated, or purified by binding it to the solid surface, the method comprising the steps of;

contacting the 5′

-ligation-tagged RNA, the first-strand cDNA, or the second-strand cDNA that contains the affinity molecule with the solid surface in the presence of reagents and under conditions that facilitate its binding to the affinity-binding substance that is attached to the solid surface, wherein the 5′

-ligation-tagged RNA, the first-strand cDNA, or the second-strand cDNA that contains the affinity molecule is bound to the surface, thereby capturing, isolating, or purifying the 5′

-ligation-tagged RNA, the first-strand cDNA, or the second-strand cDNA that contains the affinity molecule;

wherein the affinity molecule is biotin and the affinity binding substance is avidin or streptavidin;

or

wherein the affinity molecule is digoxigenin and the affinity binding substance is an antibody that specifically binds digoxigenin.

13. The method of claim 1, wherein the method further comprises using the 5′

-ligation-tagged RNA as a template for synthesis of tagged first-strand cDNA or double-stranded cDNA for use as tagged templates for DNA sequencing.

14. The method of claim 13, wherein the 5′

-ligation-tagged RNA generated has a tag on its 5′

end that exhibits a sequence tag domain, and the first-strand cDNA is synthesized using a first-strand cDNA synthesis primer that exhibits a second sequence tag domain, thereby generating 5′

- and 3′

-tagged first-strand cDNA molecules for use as sequencing templates.